Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PM INVESTMENTS AND CONSULTING, INC.

NPI: 1366659849 · LAFAYETTE, LA 70506 · Primary Care Clinic/Center · NPI assigned 05/16/2007

$1.29M
Total Medicaid Paid
69,832
Total Claims
42,812
Beneficiaries
69
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMOORE, PATRICK (OWNER)
NPI Enumeration Date05/16/2007

Related Entities

Other providers sharing the same authorized official: MOORE, PATRICK

ProviderCityStateTotal Paid
WEST COAST SURGICAL SPECIALISTS MURRIETA CA $1.73M
LOUISIANA URGENT CARE OF OPELOUSAS, LLC OPELOUSAS LA $244K
PREMIER URGENT CARE LAFAYETTE LA $42K
PATRICK DANIEL MOORE MOORE FOOT CLINIC KEARNEY NE $675.76

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,723 $75K
2019 5,790 $104K
2020 8,468 $120K
2021 13,224 $296K
2022 15,616 $280K
2023 16,104 $259K
2024 5,907 $153K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 11,205 7,903 $407K
99215 Prolong outpt/office vis 2,776 2,137 $146K
86328 6,253 3,053 $98K
96521 1,856 662 $88K
93922 2,328 1,773 $84K
93925 622 559 $68K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,852 1,600 $53K
93880 595 529 $52K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,418 1,738 $49K
J1817 Insulin for administration through dme (i.e., insulin pump) per 50 units 2,383 663 $40K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1,089 652 $26K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 381 274 $22K
99402 815 678 $21K
94060 424 380 $12K
99358 Prolong nursin fac eval 15m 1,373 932 $12K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 318 193 $12K
G0247 Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails 1,365 979 $11K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 231 183 $7K
93000 733 646 $7K
99401 484 345 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 444 322 $7K
94618 351 323 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,223 1,002 $7K
G0246 Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education 1,616 979 $4K
82962 2,211 860 $4K
93923 97 58 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 442 325 $3K
36416 4,617 2,484 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 178 133 $3K
G0245 Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education 932 736 $3K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 41 41 $3K
36415 Collection of venous blood by venipuncture 2,558 2,113 $3K
G0444 Annual depression screening, 5 to 15 minutes 1,056 641 $2K
99403 38 35 $1K
92250 35 34 $1K
99497 94 88 $1K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 303 221 $1K
99205 Prolong outpt/office vis 20 12 $1K
99417 Prolong home eval add 15m 154 66 $1K
92546 42 36 $975.46
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,113 562 $797.06
92540 27 24 $794.76
80061 Lipid panel 172 120 $674.47
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 14 12 $566.23
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 23 16 $560.16
99354 804 534 $547.46
95923 2,766 1,567 $475.00
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) 120 80 $414.29
99454 82 71 $386.11
96160 290 177 $375.12
95921 2,767 1,567 $365.93
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,979 558 $334.89
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 117 83 $324.81
82947 171 120 $234.64
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 43 36 $229.80
90688 20 19 $196.24
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 99 49 $187.81
G2011 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes 54 30 $82.50
99457 13 13 $75.00
92547 42 36 $73.20
2022F 35 34 $0.07
2026F 35 34 $0.07
G0442 Annual alcohol misuse screening, 5 to 15 minutes 466 371 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 35 15 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 79 78 $0.00
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 22 13 $0.00
G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes 427 164 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 31 20 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 33 21 $0.00